MSKCC Investigator-Initiated Clinical Trial Agreement with Kazia Therapeutics LimitedClinical Trial Agreement • October 22nd, 2020 • Kazia Therapeutics LTD • Pharmaceutical preparations • New York
Contract Type FiledOctober 22nd, 2020 Company Industry JurisdictionThis Agreement (this “Agreement”), effective as of the date of the last signature (“Effective Date”), is entered into by Memorial Sloan Kettering Cancer Center, a New York not-for-profit corporation (“MSK”), having its principal place of business at 1275 York Avenue, New York, NY 10065, on behalf of Memorial Hospital for Cancer and Allied Diseases and its Regional Sites (collectively, “MSK”), and Kazia Therapeutics Limited, a drug development company, with its principal office and place of business at Three International Towers, Level 24, 300 Barangaroo Avenue, Sydney NSW 2000, Australia (“Company”). MSK and Company may each be referred to as a “Party” to this Agreement, and referred to collectively as the “Parties.”
INVESTIGATOR INITIATED CLINICAL TRIAL AGREEMENTInvestigator Initiated Clinical Trial Agreement • October 22nd, 2020 • Kazia Therapeutics LTD • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 22nd, 2020 Company Industry JurisdictionThis Investigator Initiated Clinical Trial Agreement (“Agreement”) is made as of the 18th September 2020 (“Effective Date”) between Kazia Therapeutics Limited (ACN 063 259 754) a company incorporated in Australia with a principal place of business at L24, 300 Barangaroo Avenue, Sydney, NSW 2000, Australia (“Company”), and Dana-Farber/Partners Cancer Care, Inc., a collaboration among Dana-Farber Cancer Institute, The Brigham and Women’s Hospital, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit tax-exempt corporation organized under the laws of the Commonwealth of Massachusetts with its principal place of business at 450 Brookline Ave., Boston, MA 02215 (“Institution”) each referred to herein individually as a “Party” and collectively as the “Parties”.
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENTClinical Trial Collaboration and Supply Agreement • October 22nd, 2020 • Kazia Therapeutics LTD • Pharmaceutical preparations • California
Contract Type FiledOctober 22nd, 2020 Company Industry Jurisdiction